Rajesh Patel, senior director of product management, commercial suite, IQVIA Technologies reflects on how consolidating ...

Clinical software developer PhaseV is teaming up with another global CRO, unveiling a plan to infuse its trial design ...

RESEARCH TRIANGLE PARK, N.C. & PLEASANTON, Calif.--(BUSINESS WIRE)--IQVIA (NYSE: IQV) and Veeva Systems (NYSE: VEEV) today announced global clinical and commercial partnerships and the complete ...

Commercial: The companies have established master data and software third-party access (TPA) agreements that allow IQVIA or Veeva data to be used with each other's software or services in customer ...

Veeva Systems has unveiled its first big biotech pact since thawing relations with one-time adversary IQVIA, teaming up with Amgen to find ways to improve clinical trial processes.

RESEARCH TRIANGLE PARK, N.C. & PLEASANTON, Calif., August 18, 2025--(BUSINESS WIRE)--IQVIA (NYSE: IQV) and Veeva Systems (NYSE: VEEV) today announced global clinical and commercial partnerships and ...

"Srilekha brings deep expertise in data strategy and AI innovation,” says TRIMEDX CEO Neil de Crescenzo. "Her vision and ...

Global partnerships to help customers improve clinical and commercial efficiency and effectiveness IQVIA (NYSE: IQV) and Veeva Systems (NYSE: VEEV) today announced global clinical and commercial ...

Up to 235% increase in real-world adherence compared to published norms (20–40%), across ~850 chronic obstructive pulmonary disease (COPD) and asthma patients. >60% patients achieved an average ...

The global clinical and commercial partnerships agreed between IQVIA and Veeva Systems include the complete resolution of all pending legal disputes. The long-term agreement enables customers to use ...

LONDON, GREATER LONDON, UNITED KINGDOM, September 11, 2025 /EINPresswire.com/ -- "Get 30% Off All Global Market Reports With Code ONLINE30 – Stay Ahead Of Trade Shifts, Macroeconomic Trends, And ...